ABT’s Humira logged 2Q11 annualized sales of $8B, +25% YoY in dollars and +19% YoY in local currencies: http://finance.yahoo.com/news/Abbott-Reports-11-Percent-prnews-3161741589.html?x=0&.v=1 Humria will almost certainly become the world’s biggest-selling drug in 2012, when Lipitor goes off-patent.